Related Experiment Video
Updated: Sep 6, 2025

Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
Published on: October 20, 2016
Regional longitudinal strain patterns according to left ventricular hypertrophy in the general population
Katrine Emilie Frimodt-Møller1,2, Flemming Javier Olsen1,2, Sofie Reumert Biering-Sørensen1
1The Copenhagen City Heart Study, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Insights
Reduced basal longitudinal strain (BLS) and midventricular strain are impaired in left ventricular hypertrophy (LVH). These strain patterns independently predict major adverse cardiovascular events (MACE) in patients with LVH.
Area of Science:
- Cardiology
- Echocardiography
- Cardiovascular Imaging
Background:
- Reduced basal longitudinal strain (BLS) is a known pattern in left ventricular hypertrophy (LVH).
- The prognostic significance of this strain pattern, particularly its regional variations, in relation to cardiovascular outcomes remains unclear.
Purpose of the Study:
- To investigate the prognostic value of regional longitudinal strain, specifically BLS and midventricular strain, in individuals with and without LVH.
- To assess the association of these strain parameters with major adverse cardiovascular events (MACE).
Main Methods:
- Utilized echocardiography with speckle tracking in 1090 participants from the 4th Copenhagen City Heart Study.
- Stratified participants based on the presence of LVH (defined by LV mass index).
- Followed participants for a median of 14.7 years to record MACE (myocardial infarction, heart failure, cardiovascular death).
Main Results:
- BLS and midventricular strain showed incremental impairment across the spectrum from normal geometry to LVH.
- Both BLS and midventricular strain were independently associated with MACE in participants with LVH (P=0.041 for both).
- No significant association was found between these strain parameters and MACE in participants without LVH.
Conclusions:
- Impaired BLS and midventricular strain are characteristic of LVH and worsen progressively with increasing LVH.
- These regional strain measures serve as independent predictors of MACE in individuals with LVH.
Aims:
A pattern of reduced basal longitudinal strain (BLS) is often observed with left ventricular (LV) hypertrophy (LVH). Whether this pattern is associated with poor outcome is unclear. We aimed to evaluate the prognostic value of regional longitudinal strain according to LV geometry.
Methods And Results:
We investigated participants in the 4th Copenhagen City Heart Study who had an echocardiogram with speckle tracking performed. Participants were stratified according to the presence of LVH (LV mass index ≥116 g/m2 for men and ≥96 g/m2 for women). The outcome was major adverse cardiovascular events (MACE) defined as a composite of myocardial infarction, heart failure, and/or cardiovascular death. The study population consisted of 1090 participants. Mean LVEF was 60% and 160 (15%) had LVH. During a median follow-up of 14.7 years, there were 137 events. Both BLS and midventricular strain, but not apical strain, became incrementally impaired in the spectrum from normal to hypertensives subjects without LVH, and to participants with hypertension and LVH. After multivariable adjustment, BLS and midventricular strain were independently associated with MACE in participants with LVH (BLS: HR 1.08, 95% CI 1.00-1.17, P = 0.041; midventricular strain: HR 1.10, 95% CI 1.00-1.21, P = 0.041) but not in participants without LVH (BLS: HR 0.96, 95% CI 0.90-1.01, P = 0.13; midventricular strain: HR 0.97, 95% CI 0.91-1.03, P = 0.36).
Conclusion:
BLS and midventricular strain, but not apical strain, become incrementally impaired in the spectrum from normal geometry to LVH, and are independently associated with MACE in participants with LVH.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

